Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet

C Gilbert, A Azzi, N Goyette, SX Lin… - Antimicrobial agents and …, 2011 - Am Soc Microbiol
Selection of human cytomegalovirus variants in the presence of ganciclovir or foscarnet led
to 18 DNA polymerase mutations, 14 of which had not been previously studied. Using …

Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy

S Chou - Journal of clinical virology, 2011 - Elsevier
BACKGROUND: Cytomegalovirus UL54 DNA polymerase mutations observed in clinical
specimens are of diagnostic significance if confirmed to affect antiviral drug susceptibility …

Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene

S Chou - Antiviral research, 2017 - Elsevier
Human cytomegalovirus UL54 DNA polymerase gene mutations that confer foscarnet
resistance in clinical practice typically cluster in the amino terminal 2, palm and finger …

Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens

S Chou, GI Marousek, LC Van Wechel… - Antimicrobial agents …, 2007 - Am Soc Microbiol
Recombinant phenotyping of cytomegalovirus (CMV) pol region III mutations from clinical
specimens showed that T813S and G841A each conferred foscarnet resistance and …

New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure

C Gilbert, G Boivin - Antimicrobial agents and chemotherapy, 2005 - Am Soc Microbiol
We developed a new reporter cell line for human cytomegalovirus (HCMV) drug
susceptibility testing. This cell line was obtained by incorporating the luciferase reporter …

[HTML][HTML] High impact of an expanded restriction fragment length polymorphism assay on detection of ganciclovir-resistant UL97 mutants of human cytomegalovirus

T Eckle, G Jahn, K Hamprecht - Antimicrobial agents and …, 2003 - Am Soc Microbiol
The advent of highly active antiretroviral therapy for human immunodeficiency virus-infected
individuals has reduced the emergence of ganciclovir (GCV)-resistant human …

A Novel Mutation in the Ul54 Gene of Human Cytomegalovirus Isolates that Confers Resistance to Foscarnet

A Ducancelle, G Champier, S Alain, F Petit… - 2006 - journals.sagepub.com
Foscarnet is currently licensed for the treatment of human cytomegalovirus (HCMV)
infection. Mutations proven to confer resistance to foscarnet have mostly been mapped to …

Aciclovir selects for ganciclovir‐cross‐resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein

D Michel, S Höhn, T Haller, D Jun… - Journal of medical …, 2001 - Wiley Online Library
Phenotypically, ganciclovir‐resistant human cytomegalovirus strains could be selected by
aciclovir as effectively as by ganciclovir in vitro. Three clinical human cytomegalovirus …

Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial

S Chou, G Boivin, J Ives, R Elston - The Journal of infectious …, 2014 - academic.oup.com
Background. In a large randomized trial comparing oral valganciclovir and intravenous
ganciclovir for treatment of cytomegalovirus disease in solid organ transplantation …

Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance

S Chou - Antimicrobial agents and chemotherapy, 2010 - Am Soc Microbiol
ABSTRACT A strain of human cytomegalovirus, T2211, modified from standard laboratory
strain AD169 to contain a secreted alkaline phosphatase reporter gene for rapid viral …